News and Events
Amgen Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight MariTide is the First Obesity Treatment With Monthly or Less Frequent Dosing to Demonstrate Safe and Effective Weight Loss in a Phase 2 Study In People With Type 2 Diabetes Living With Obesity or Overweight [...]
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
– Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of thyroxine and vitamin A and to demonstrate benefit on cardiovascular outcomes – Attruby demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM [...]
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically significant risk reduction of 36% on All-Cause Mortality (ACM) alone at Month 36 within the Open Label Extension – The continued curve separation of the composite endpoint of ACM and recurrent cardiovascular-related hospitalizations (CVH) emphasizes the importance of early [...]
Promoting Cardiovascular Health Equity Association of Black Cardiologists Practical Model for Community-Engaged
Despite advancements in the assessment and treatment of cardiovascular disease (CVD) and its risk factors, certain populations remain disproportionately affected by suboptimalCVD outcomes. Hispanic and Non-Hispanic Black Americans have overall worse cardiovascular health (CVH) 1 and higher CVD-related mortality rates than their Non-Hispanic White counterparts. These disparities arise from systemic health inequities deeply rooted in racism that lead [...]
Improving Health Care Access and Outcomes for Minority and High-Risk Populations
The Association of Black Cardiologists (ABC) convened a roundtable dedicated to advancing equity and addressing health disparities in cardiovascular health. Attended by a diverse group of nearly 60 stakeholders, including government officials, clinicians, researchers, and patient advocates, the symposium focused on the “Improving Health Care Access and Outcomes for Minority and High-Risk Populations.” Participants delved into the [...]
Nurturing Diverse Generations of the Medical Workforce for Success With Authenticity: An Association of Black Cardiologists’ Roundtable
The COVID-19 pandemic exposed the consequences of systemic racism in the United States with Black, Hispanic, and other racial and ethnic diverse populations dying at disproportionately higher rates than White Americans. Addressing the social and health disparities amplified by COVID-19 requires in part restructuring of the healthcare system, particularly the diversity of the healthcare workforce to better reflect [...]
Upcoming Events
The State of Electrophysiology: Gaps, Growth, and Global Perspectives
April 25 @ 3:30 pm - May 11 @ 4:30 pmESCAPE: Emory Symposium on Coronary Atherosclerosis Prevention & Education
June 26 - June 28